Xeomin

Xeomin is a prescription neurotoxin derived from Clostridium Botulinum Type A, used for temporary muscle relaxation. It contains no complexing proteins and is administered via injection. This product is manufactured in the EU and intended for intraglandular or intramuscular use. Suitable for adults seeking neuromodulation therapy.

Xeomin is used to temporarily reduce moderate to severe frown lines between the eyebrows. It may also address certain muscle-related conditions, such as cervical dystonia or blepharospasm, by relaxing overactive muscles. Patients often seek Xeomin for cosmetic enhancements or medical conditions involving muscle spasms. It is not a permanent solution and requires repeated treatments.

Xeomin works by blocking nerve signals to targeted muscles, leading to temporary muscle relaxation. Users may notice reduced muscle activity in treated areas within days of injection. The effects typically last 3–6 months before gradual muscle activity returns. Some individuals experience mild discomfort at the injection site.

Xeomin should only be administered by a licensed healthcare professional trained in its use. Avoid rubbing or massaging the injection site immediately after treatment to prevent spreading to unintended areas. Inform your provider of any allergies or medical conditions before use. Keep out of reach of children and pets.

Xeomin may interact with medications that affect muscle activity, such as muscle relaxants or certain antibiotics. Alcohol and other substances that cause drowsiness could increase the risk of side effects. Always disclose all medications and supplements to your healthcare provider. No known interactions require avoidance of common foods or beverages.